PCM
GILD icon

Penserra Capital Management’s Gilead Sciences GILD Stock Holding History

Penserra Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Sell
105
-8,585
-99% -$1.13M ﹤0.01% 893
2026
Q1 		$1.21M Buy
8,690
+8,585
+8,176% +$1.2M 0.01% 429
2025
Q4 		$12K Buy
105
+3
+3% +$365 ﹤0.01% 840
2025
Q3 		$11K Sell
102
-1,266
-93% -$144K ﹤0.01% 842
2025
Q2 		$151K Buy
1,368
+1,266
+1,241% +$135K ﹤0.01% 676
2025
Q1 		$11K Sell
102
-3,156
-97% -$326K ﹤0.01% 889
2024
Q4 		$300K Buy
3,258
+3,156
+3,094% +$284K 0.01% 660
2024
Q3 		$8K Hold
102
– – ﹤0.01% 900
2024
Q2 		$7K Hold
102
– – ﹤0.01% 1037
2024
Q1 		$7K Sell
102
-5,665
-98% -$436K ﹤0.01% 974
2023
Q4 		$466K Sell
5,767
-1,210
-17% -$94.2K 0.01% 547
2023
Q3 		$522K Sell
6,977
-1,105
-14% -$85K 0.01% 494
2023
Q2 		$622K Buy
8,082
+7,647
+1,758% +$610K 0.01% 460
2023
Q1 		$35K Sell
435
-34,901
-99% -$2.89M ﹤0.01% 871
2022
Q4 		$3.03M Buy
+35,336
New +$2.8M 0.07% 270
2018
Q4 		– Sell
-4,600
Closed -$355K – 687
2018
Q3 		$355K Buy
4,600
+650
+16% +$49.1K 0.02% 357
2018
Q2 		$279K Buy
3,950
+150
+4% +$10.6K 0.02% 288
2018
Q1 		$286K Buy
3,800
+300
+9% +$23.8K 0.03% 230
2017
Q4 		$250K Buy
3,500
+550
+19% +$41.8K 0.03% 209
2017
Q3 		$246K Buy
2,950
+350
+13% +$26.8K 0.06% 170
2017
Q2 		$184K Buy
2,600
+944
+57% +$62.8K 0.07% 222
2017
Q1 		$112K Buy
1,656
+144
+10% +$10.1K 0.01% 289
2016
Q4 		$108K Buy
1,512
+216
+17% +$16.1K 0.01% 321
2016
Q3 		$102K Buy
1,296
+774
+148% +$62.9K 0.01% 275
2016
Q2 		$44K Buy
522
+174
+50% +$15.4K 0.01% 365
2016
Q1 		$31K Buy
348
+56
+19% +$5.05K ﹤0.01% 373
2015
Q4 		$29K Buy
+292
New +$30.4K ﹤0.01% 340

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Penserra Capital Management's GILD Position: Q2 2026 in Review

Penserra Capital Management reduced its Gilead Sciences (GILD) stake by 99% in Q2 2026, selling an estimated $1.13M and leaving 105 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Penserra Capital Management first reported a position in GILD in Q4 2015 and has held it in 27 quarters since. The position peaked at $3.03M in Q4 2022. 2,290 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Penserra Capital Management held 105 shares of Gilead Sciences worth $13K as of Q2 2026.
  • Penserra Capital Management sold 8,585 Gilead Sciences shares in Q2 2026, an estimated $1.13M.
  • Gilead Sciences made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #893 holding.
  • Penserra Capital Management first reported a position in Gilead Sciences in Q4 2015 and has held it in 27 quarters since.
  • Penserra Capital Management's Gilead Sciences position peaked at $3.03M in Q4 2022.
  • 2,290 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.